Apparatus and method for monitoring deep tissue temperature using broadband diffuse optical spectroscopy

• US 20060111622A1
• Filed: 10/07/2005
• Published: 05/25/2006
• Est. Priority Date: 10/07/2004
• Status: Abandoned Application

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Merritt, Sean, Durkin, Anthony J., Tromberg, Bruce J., Cerussi, Albert E.
• Application Number:
  US11/246,369
• Publication Number:
  US 20060111622A1
• Time in Patent Office: Days
• US Class Current: 600/315
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/01 Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue clinical contact thermometers G01K13/20

Abstract

A method for noninvasively determining deep tissue temperature comprises measuring data relating to spectral shifts of chromophore absorption in tissue using broadband diffuse optical spectroscopy and generating a temperature reading corresponding to the spectral shift of an absorption peak of the chromophore. A bound water correction is made to the spectral shift. A frequency domain measurement at multiple wavelengths is made to determine the absolute absorption and scattering values between 600 and 1050 nm. The measurement of an absolute absorption comprises measuring an absolute absorption coefficient of selected tissue and further comprising deducing concentrations of tissue composition including lipids, deducing information related to heterogeneity and integrity of tissue matrix, and deducing temperature heterogeneity related to vulnerable plaque in vascular tissue. The measurement comprises making a measurement in the range of 600-1100 nm to interrogate a vessel wall in the presence of blood.

Claims

1. A method for noninvasively determining tissue temperature comprising:

measuring data relating to spectral shifts of chromophore absorption in tissue using broadband diffuse optical spectroscopy; and

generating a temperature reading corresponding to the spectral shift of an absorption peak of the chromophore.

2. The method of claim 1 further comprising performing a bound water correction to the spectral shift.

3. The method of claim 1 where measuring spectral shifts comprises making a frequency domain measurement at multiple wavelengths to determine the absolute absorption and scattering values at the multiple wavelengths.

4. The method of claim 3 where measuring spectral shifts further comprises scaling with the frequency domain measurements to provide an absolute quantitative absorption spectrum in the wavelength region between 600 and 1050 nm.

5. The method of claim 1 where measuring spectral shifts comprises making a measurement of an absolute scattering and absorption.

6. The method of claim 5 where making a measurement of an absolute absorption comprises measuring an absolute absorption coefficient of selected tissue and further comprising deducing concentrations of tissue composition including lipids.

7. The method of claim 5 where making a measurement of an absolute scattering comprises measuring an absolute scattering coefficient of selected tissue and further comprising deducing information related to heterogeneity and integrity of tissue matrix.

8. The method of claim 1 further comprising deducing temperature heterogeneity related to vulnerable plaque in vascular tissue.

9. The method of claim 5 where making a measurement of an absolute scattering and absorption comprises making a measurement in the range of 600-1100 nm to interrogate a vessel wall in the presence of blood.

10. The method of claim 1 where generating a temperature reading corresponding to the spectral shift of an absorption peak of the chromophore comprises:

providing bound water shift, bws, for water chromophore as a baseline measurements corrected for effects due to macromolecule binding to provide a library of temperature dependent water absorption spectra at all temperatures over a predetermined temperature range;

weighting the broadband DOS data such that only the absorption values within a predetermined spectral window which included a selected water absorption peak were used; and

finding the best fit between (1) the measured water absorption spectrum and (2) the sum of a flat baseline chromophore and a water absorption spectrum at a specific temperature from library of temperature dependent water absorption spectra.

11. The method of claim 10 further comprising performing a chromophore fit in which the water absorption spectrum used is at the temperature determined by the previous temperature fit, determining new chromophore values, and repeating finding the best fit with the new chromophore values being fixed, where finding the best fit is performed in a loop which fits for chromophore values and follows fits for temperature, a final temperature being determined when the difference between two consecutive fit temperatures is less than a predetermined value.

12. The method of claim 11 where predetermined value for the difference between two consecutive fit temperatures is 0.1°

C.

13. The method of claim 10 where weighting the broadband DOS data such that only the absorption values within a predetermined spectral window comprises weighting the broadband DOS data such that only the absorption values within a spectral window defined from 935-1000 nm.

14. A method for noninvasively determining an unknown tissue chromophore comprising:

measuring data relating to spectral shifts of the unknown chromophore absorption in tissue using broadband diffuse optical spectroscopy;

generating a temperature reading corresponding to a spectral shift of an absorption peak of the unknown chromophore; and

matching a spectral shift of an absorption peak of a known chromophore selected from a library to the spectral shift of an absorption peak of the unknown chromophore to obtain a best fit among a plurality of known chromophore candidates to identify the unknown chromophore with the known chromophore.

15. A method for noninvasively detecting vulnerable plaque in vascular tissue comprising:

measuring data relating to spectral shifts of chromophore absorption in tissue using broadband diffuse optical spectroscopy corresponding to at least one chromophore correlated with vulnerable plaque in vascular tissue; and

generating at least one temperature reading corresponding to the spectral shift of an absorption peak of the at least one chromophore to identify temperature heterogeneity in the vascular tissue and presence of vulnerable plaque.

16. An apparatus for noninvasively determining deep tissue temperature comprising:

means for measuring data relating to spectral shifts of chromophore absorption in tissue using broadband diffuse optical spectroscopy; and

means for generating a temperature reading corresponding to the spectral shift of an absorption peak of the chromophore.

17. The apparatus of claim 16 further comprising means for performing a bound water correction to the spectral shift.

18. The apparatus of claim 16 where the means for measuring spectral shifts comprises means for making a frequency domain measurement at multiple wavelengths to determine the absolute absorption and scattering values at the multiple wavelengths.

19. The apparatus of claim 18 where the means for measuring spectral shifts further comprises means for scaling with the frequency domain measurements to provide an absolute quantitative absorption spectrum in the wavelength region between 600 and 1050 nm.

20. The apparatus of claim 16 where the means for measuring spectral shifts comprises means for making a measurement of an absolute scattering and absorption.

21. The apparatus of claim 20 where the means for making a measurement of an absolute absorption comprises means for measuring an absolute absorption coefficient of selected tissue and further comprising means for deducing concentrations of tissue composition including lipids.

22. The apparatus of claim 20 where the means for making a measurement of an absolute scattering comprises means for measuring an absolute scattering coefficient of selected tissue and further comprising means for deducing information related to heterogeneity and integrity of tissue matrix.

23. The apparatus of claim 16 further comprising means for deduce temperature heterogeneity related to vulnerable plaque in vascular tissue.

24. The apparatus of claim 20 where the means for making a measurement of an absolute scattering and absorption comprises means for making a measurement in the range of 600-1100 nm to interrogate a vessel wall in the presence of blood.

25. The apparatus of claim 16 where the means for generating a temperature reading corresponding to the spectral shift of an absorption peak of the chromophore comprises:

means for providing bound water shift, bws, for water chromophore as a baseline measurements corrected for effects due to macromolecule binding to provide a library of temperature dependent water absorption spectra at all temperatures over a predetermined temperature range;

means for weighting the broadband DOS data such that only the absorption values within a predetermined spectral window which included a selected water absorption peak were used; and

means for finding the best fit between (1) the measured water absorption spectrum and (2) the sum of a flat baseline chromophore and a water absorption spectrum at a specific temperature from library of temperature dependent water absorption spectra.

26. The apparatus of claim 25 further means for comprising performing a chromophore fit in which the water absorption spectrum used is at the temperature determined by the previous temperature fit, means for determining new chromophore values, and means for repeating finding the best fit with the new chromophore values being fixed, where the means for finding the best fit performs a loop which fits for chromophore values and which then fits for temperature, a final temperature being determined when the difference between two consecutive fit temperatures is less than a predetermined value.

27. The apparatus of claim 25 where the means for weighting the broadband DOS data such that only the absorption values within a predetermined spectral window comprises means for weighting the broadband DOS data such that only the absorption values within a spectral window defined from 935-1000 nm.

28. An apparatus for noninvasively determining an unknown tissue chromophore comprising:

means for measuring data relating to spectral shifts of the unknown chromophore absorption in tissue using broadband diffuse optical spectroscopy;

means for generating a temperature reading corresponding to a spectral shift of an absorption peak of the unknown chromophore; and

means for matching a spectral shift of an absorption peak of a known chromophore selected from a library to the spectral shift of an absorption peak of the unknown chromophore to obtain a best fit among a plurality of known chromophore candidates to identify the unknown chromophore with the known chromophore.

29. An apparatus for noninvasively detecting vulnerable plaque in vascular tissue comprising:

means for measuring data relating to spectral shifts of chromophore absorption in tissue using broadband diffuse optical spectroscopy corresponding to at least one chromophore correlated with vulnerable plaque in vascular tissue; and

means for generating at least one temperature reading corresponding to the spectral shift of an absorption peak of the at least one chromophore to identify temperature heterogeneity in the vascular tissue and presence of vulnerable plaque.